Commonwealth 发表于 2025-3-25 03:57:36

Submitted on: 14 January 2015.
Revised on: 11 February 2015.
Accepted on: 06 April 2015.

___________________ACTA ONCOLOGICA---TAYLOR & FRANCIS LTD

ureter 发表于 2025-3-25 10:02:14

Submitted on: 29 March 2022.
Revised on: 24 June 2022.
Accepted on: 20 July 2022.

___________________ACTA ONCOLOGICA---TAYLOR & FRANCIS LTD

Bureaucracy 发表于 2025-3-25 15:43:37

Submitted on: 12 September 2009.
Revised on: 30 October 2009.
Accepted on: 15 December 2009.

___________________ACTA ONCOLOGICA---TAYLOR & FRANCIS LTD

Forsake 发表于 2025-3-25 17:56:26

Submitted on: 22 April 2002.
Revised on: 24 June 2002.
Accepted on: 29 July 2002.

___________________ACTA ONCOLOGICA---TAYLOR & FRANCIS LTD

stratum-corneum 发表于 2025-3-25 20:26:35

http://reply.papertrans.cn/1/5/414/414-25.png

botany 发表于 2025-3-26 03:41:58

Submitted on: 03 April 2004.
Revised on: 11 May 2004.
Accepted on: 28 June 2004.

___________________ACTA ONCOLOGICA---TAYLOR & FRANCIS LTD

Indict 发表于 2025-3-26 07:59:10

Submitted on: 13 April 2022.
Revised on: 07 July 2022.
Accepted on: 14 August 2022.

___________________ACTA ONCOLOGICA---TAYLOR & FRANCIS LTD

PATHY 发表于 2025-3-26 10:39:27

http://reply.papertrans.cn/1/5/414/414-28.png

chemical-peel 发表于 2025-3-26 16:38:37

http://reply.papertrans.cn/1/5/414/414-29.png

你敢命令 发表于 2025-3-26 20:12:54

http://reply.papertrans.cn/1/5/414/414-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊ACTA ONCOLOGICA 2024/2025影响因子:2.779 (ACTA ONCOL) (0284-186X). (ONCOLOGY)(肿瘤学)Science Citation Index Expanded